SFXN2 and nonpapillary renal cell carcinoma: Our results demonstrated that the downregulation of CHST6, SFXN2, and GRIK3 was closely associated with poor survival outcomes in ccRCC patients (Figure 4E,F), which aligns well with the oncogenic role of miR-134-5p in ccRCC.